-
公开(公告)号:US11274149B2
公开(公告)日:2022-03-15
申请号:US15581573
申请日:2017-04-28
申请人: Vaccinex, Inc.
摘要: Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.
-
公开(公告)号:US20170306017A1
公开(公告)日:2017-10-26
申请号:US15581573
申请日:2017-04-28
申请人: Vaccinex, Inc.
IPC分类号: C07K16/28 , A61K39/395 , C07K16/30 , A61K45/06 , A61K39/00
CPC分类号: C07K16/2803 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/18 , C07K16/2896 , C07K16/30 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.
-
公开(公告)号:US09090709B2
公开(公告)日:2015-07-28
申请号:US13828506
申请日:2013-03-14
申请人: VACCINEX, INC.
IPC分类号: C07K16/28 , C07K14/705
CPC分类号: C07K14/70596 , C07K16/2803 , C07K16/2896 , C07K2317/34
摘要: The invention relates to epitopes of SEMA4D and to binding agents, such as antibodies, that specifically bind to SEMA4D.
摘要翻译: 本发明涉及SEMA4D的表位和特异性结合SEMA4D的结合剂,如抗体。
-
4.
公开(公告)号:US20140072578A1
公开(公告)日:2014-03-13
申请号:US13797048
申请日:2013-03-12
申请人: Vaccinex, Inc.
IPC分类号: C07K16/18
CPC分类号: C07K16/2803 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/18 , C07K16/2896 , C07K16/30 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD 100 monoclonal antibodies have been developed to neutralize CD100.
摘要翻译: 提供组合物和方法用于治疗与CD100相关的疾病,包括某些自身免疫疾病,炎性疾病和癌症。 特别地,已经开发了抗-CD100单克隆抗体来中和CD100。
-
公开(公告)号:US12006364B2
公开(公告)日:2024-06-11
申请号:US17588427
申请日:2022-01-31
申请人: Vaccinex, Inc.
IPC分类号: A61K39/00 , A61K38/17 , A61K39/395 , A61K45/06 , A61P25/00 , C07K16/18 , C07K16/28 , C07K16/30
CPC分类号: C07K16/2803 , A61K38/1774 , A61K39/0001 , A61K39/3955 , A61K39/39558 , A61K39/4611 , A61K39/46433 , A61K45/06 , A61P25/00 , C07K16/18 , C07K16/2896 , C07K16/30 , A61K2039/505 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.
-
公开(公告)号:US20220185884A1
公开(公告)日:2022-06-16
申请号:US17588427
申请日:2022-01-31
申请人: Vaccinex, Inc.
IPC分类号: C07K16/28 , C07K16/18 , A61K39/395 , A61K45/06 , C07K16/30
摘要: Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.
-
公开(公告)号:US20200317788A1
公开(公告)日:2020-10-08
申请号:US16832170
申请日:2020-03-27
申请人: Vaccinex, Inc.
摘要: The disclosure relates to methods for treating cancer comprising determining certain patient biomarker levels prior to treatment.
-
公开(公告)号:US09605055B2
公开(公告)日:2017-03-28
申请号:US13797048
申请日:2013-03-12
申请人: Vaccinex, Inc.
CPC分类号: C07K16/2803 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/18 , C07K16/2896 , C07K16/30 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.
-
公开(公告)号:US09676840B2
公开(公告)日:2017-06-13
申请号:US13800713
申请日:2013-03-13
申请人: Vaccinex, Inc.
CPC分类号: C07K16/2803 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/18 , C07K16/2896 , C07K16/30 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.
-
10.
公开(公告)号:US20130274449A1
公开(公告)日:2013-10-17
申请号:US13800713
申请日:2013-03-13
申请人: Vaccinex, Inc.
IPC分类号: C07K16/28
CPC分类号: C07K16/2803 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/18 , C07K16/2896 , C07K16/30 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.
摘要翻译: 提供组合物和方法用于治疗与CD100相关的疾病,包括某些自身免疫疾病,炎性疾病和癌症。 特别地,已经开发了抗CD100单克隆抗体来中和CD100。
-
-
-
-
-
-
-
-
-